Venture Capital Investors

BioAdvance Ventures

BioAdvance Ventures makes VC investments in techn-focused companies.

Venture Investor Overview

Venture Investor
BioAdvance Ventures
Status
InActive
Investor Type
Venture Capital
Activity Level
57 transactions
Funds Raised
Unknown
Industry Focus
Biopharmaceutical
Medical Devices & Instruments

Contact Information

Contact
Barbara Schilberg
Title
Managing Director
Mailing Address
170 North Radnor Chester Rd. 350
Radnor, PA 19087
USA
Phone
(610) 230-0544
Website
www.bioadvance.com
Email Address
[email protected]

Background Information

Overview
BioAdvance Ventures is an innovative new venture fund formed to invest in seed and early stage life science companies, located primarily in Southeastern Pennsylvania. The fund is sponsored by BioAdvance, the Biotechnology Greenhouse Corporation of Southeastern Pennsylvania and is managed by Quaker BioVentures.
Profile
BioAdvance Ventures LinkedIn Company Profile
Social Media
BioAdvance Ventures Company Twitter Account
Company News
BioAdvance Ventures News
Facebook
BioAdvance Ventures on Facebook
YouTube
BioAdvance Ventures on YouTube
Last Transaction
7/19/2023

Transaction History

Our records indicate that BioAdvance Ventures invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
KayoThera
7/19/2023
$5,200,000
Palvella Therapeutics
1/9/2023
$37,700,000
Senzo
12/14/2022
$1,900,000
Innervace
9/8/2022
$40,000,000
Senzo
7/21/2022
$2,000,000
Halo Labs
7/11/2022
$6,000,000
KayoThera
3/16/2022
$8,000,000
Wellsheet
6/12/2020
$3,800,000
Palvella Therapeutics
6/1/2020
$45,000,000
Halo Labs
4/7/2020
$12,000,000
Ride Health
1/8/2020
$6,200,000
Renovacor
8/16/2019
$11,000,000
Pillo Health
5/30/2019
$11,000,000
Halo Labs
12/21/2018
$5,600,000
Bainbridge Health
6/20/2018
$1,600,000
Opsidio
9/26/2017
Unknown
Keriton
2/28/2017
$1,000,000
Genome Profiling
9/30/2016
$100,000
Olive Devices
9/30/2016
$50,000
RiboNova
3/31/2016
$250,000
NobleMD
3/31/2016
$400,000
OnCora Medical
3/14/2016
$1,200,000
CarePartners Plus
12/31/2015
$30,000
Hsiri Therapeutics
12/31/2015
$70,000
Cohero Health
12/23/2015
$2,000,000
Merganser Biotech
2/19/2015
$28,000,000
Galleon Pharmaceuticals
12/31/2014
$25,000,000
WellTrackOne
3/28/2014
$1,500,000
Jenrin Discovery
12/31/2012
$520,000
Niiki Pharma
12/31/2012
$85,000
Merganser Biotech
12/31/2012
$138,000
Novira Therapeutics
8/23/2012
$23,000,000
Ceptaris Therapeutics
6/5/2012
$10,000,000
Leversense
3/31/2011
$300,000
Immunome
3/31/2011
$50,000
Phoenix S&T
12/31/2010
$50,000
Immunome
6/30/2010
Unknown
Treventis
9/30/2009
$550,000
Avid Radiopharmaceuticals
5/21/2009
$34,500,000
Formae
9/12/2008
$500,000
Phoenix S&T
9/12/2008
$500,000
Niiki Pharma
9/12/2008
$500,000
NuPathe
7/24/2008
$30,000,000
Diasome Pharmaceuticals
4/15/2008
Unknown
Marillion Pharmaceuticals
6/30/2007
$650,000
Avid Radiopharmaceuticals
5/9/2007
$26,000,000
Ceptaris Therapeutics
11/13/2006
$4,000,000
NuPathe
9/13/2006
$15,000,000
Midway Pharmaceuticals
6/30/2006
$570,000
NuPathe
11/8/2005
$500,000
Protez Pharmaceuticals
9/24/2005
$15,000,000
Immune Control
7/14/2005
$11,300,000
Jenrin Discovery
3/31/2005
$500,000
InfraScan
3/31/2005
$450,000
Galleon Pharmaceuticals
3/31/2005
$500,000
Marillion Pharmaceuticals
3/31/2005
$500,000
Melior Discovery
1/25/2005
$500,000

 

Investor Contacts

Title
Name
Email & Social
Managing Director
Barbara Schilberg
  Barbara Schilberg LinkedIn Profile  Barbara Schilberg Twitter Account  Barbara Schilberg News  Barbara Schilberg on Facebook

 

Funds

No fund closings have been recorded for this company.

 

Portfolio Companies

BioAdvance Ventures has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Avid Radiopharmaceuticals
Bainbridge Health
CarePartners Plus
Ceptaris Therapeutics
Cohero Health
Diasome Pharmaceuticals
Formae
Galleon Pharmaceuticals
Genome Profiling
Halo Labs
Hsiri Therapeutics
Immune Control
Immunome
InfraScan
Innervace
Jenrin Discovery
KayoThera
Keriton
Leversense
Marillion Pharmaceuticals
Melior Discovery
Merganser Biotech
Midway Pharmaceuticals
Niiki Pharma
NobleMD
Novira Therapeutics
NuPathe
Olive Devices
OnCora Medical
Opsidio
Palvella Therapeutics
Phoenix S&T
Pillo Health
Protez Pharmaceuticals
Renovacor
RiboNova
Ride Health
Senzo
Treventis
Wellsheet
WellTrackOne

 

 

 

 

Browse more venture capital investors:

Bio*One Capital | BioBee

 

Share this article

 

About Our Venture Capital Investors Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.